GlassScriptPhysician profile
Diana M Alvarez
NPI 1285096099
$2,722.92
in general payments reported to CMS, 2019-2025
23 companies · $497 in 2025
The $497 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $70.99 · 2020: $180 · 2021: $62.14 · 2022: $443 · 2023: $887 · 2024: $584 · 2025: $497.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,967.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,967.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $445.79 | 2023-2025 | Aurora Ev-Icd Mri Surescan, Linq II, Cobalt Dr Mri Surescan |
| E.R. Squibb & Sons, L.L.C. | $394.94 | 2019-2025 | Camzyos, Eliquis |
| Boston Scientific Corporation | $320.69 | 2021-2025 | Watchman Flx, Bodyguardian |
| Novartis Pharmaceuticals Corporation | $275.89 | 2023-2025 | |
| Atricure, INC. | $213.50 | 2022-2023 | |
| Abiomed | $152.96 | 2023 | Impella |
| Actelion Pharmaceuticals US, INC. | $125.33 | 2023 | Uptravi, Opsumit |
| Abbvie INC. | $123.21 | 2020 | |
| Pfizer INC. | $101.51 | 2021-2025 | |
| Angiodynamics, INC. | $100.00 | 2024 | Alphavac |
| Astellas Pharma US INC | $99.00 | 2022 | |
| Cvrx, INC. | $70.57 | 2024-2025 | Barostim Neo System |
| Baxter Healthcare | $45.59 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.68 | 2020-2021 | |
| Allergan, INC. | $38.37 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $37.06 | 2022-2023 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $32.13 | 2024 | Lifevest |
| Tesaro, INC. | $21.82 | 2019 | |
| Cardiva Medical, INC. | $19.57 | 2025 | Optowire |
| Astrazeneca Pharmaceuticals LP | $19.48 | 2020 | |
| Daiichi Sankyo INC. | $16.14 | 2023 | Injectafer |
| Amgen INC. | $15.70 | 2025 | Repatha |
| Olympus America INC. | $13.99 | 2024 | Visera Elite II Video System Center |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diana Alvarez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.